Company: NOTV
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023370
Chunk: 29

Company: Inotiv, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 29
---
093 8,451 9,390  $5,473 $7,022 $9,932 $12,594 Geographic InformationThe following represents revenue originating in entities physically located in the identified geographic area:Three Months EndedMarch 31,Six Months EndedMarch 31,2025202420252024United States$112,151 $102,429 $209,550 $214,198 Netherlands4,603 9,724 20,437 27,786 Other7,569 6,882 14,212 12,552 $124,323 $119,035 $244,199 $254,536 

15

Long-lived assets shown below include property and equipment, net. The following represents long-lived assets where they are physically located:March 31,September 30,20252024United States$161,614 $167,772 Netherlands6,580 7,159 Other12,961 13,397 $181,155 $188,328 

4.    DEBT

Long-term debt as of March 31, 2025 and September 30, 2024 is detailed in the table below. March 31, 2025September 30, 2024Seller Note – Bolder BioPath (Related party)$263 $376 Seller Note – Preclinical Research Services— 464 Seller Payable - Orient BioResource Center3,235 3,700 Seller Note – Histion (Related party)12 84 Second Lien Notes20,485 17,846 Convertible Senior Notes113,124 109,979 Term Loan Facility, DDTL and Incremental Term Loans271,864 272,840 Total debt before unamortized debt issuance costs$408,983 $405,289 Less: Debt issuance costs not amortized(9,443)(11,950)Total debt, net of unamortized debt issuance costs$399,540 $393,339 Less: Current portion(7,146)(3,538)Total Long-term debt$392,394 $389,801 Revolving Credit FacilityAs of March 31, 2025 and September 30, 2024, the Company had no outstanding balance on the revolving credit facility. Refer to the condensed consolidated statements of cash flows for information related to borrowings and payments on